FATE THERAPEUTICS INC. - COMMON STOCK

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

05 3月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

01 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

26 2月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

15 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02 2月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

08 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 12月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

08 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results

25 10月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming September Investor Conferences

31 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

08 8月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results

28 7月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming June Investor Conferences

31 5月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates

03 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results

24 4月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

03 3月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

28 2月 2023 16:01:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial Results

13 2月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Announces Termination of Collaboration Agreement with Janssen, Pipeline Prioritization, Next-Generation Programs, and Key 2023 Initiatives

05 1月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell Therapies at 2022 ASH Annual Meeting

13 12月 2022 08:00:02 条件 Nasdaq GlobeNewswire